AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2017

Jun 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2017-06-23

Reporting Person: Biller Scott (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-23	Common stock	M	3000	$0.4675	Acquired	6264	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-23	Stock option (right to buy)	$0.4675	M	3000	Disposed	2020-12-06	Common stock (3000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	46470	Indirect

Footnotes

F1: Shares held by a spousal lifetime access trust, of which the reporting person's wife is trustee.

F2: This option was granted on December 7, 2010. The shares underlying this option vest as to 25% of the shares on September 20, 2011, with the remaining 75% vesting in 36 equal monthly installments thereafter.